|
DK178590D0
(da)
|
1990-07-26 |
1990-07-26 |
Novo Nordisk As |
1,4-disubstituerede piperaziner
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
WO1994012461A1
(en)
|
1992-12-02 |
1994-06-09 |
Pfizer Inc. |
Catechol diethers as selective pdeiv inhibitors
|
|
DE4323192A1
(de)
|
1993-07-10 |
1995-01-12 |
Basf Ag |
Verfahren zur Herstellung von Homo- und Copolymerisaten von Alk-1-enen
|
|
DE4325846C1
(de)
|
1993-07-31 |
1995-01-19 |
Herberts Gmbh |
Verwendung von Furan-modifizierten aromatischen Pinakolderivaten als Initiatoren und Furan-modifizierte aromatische Pinakolderivate als solche
|
|
DE4343286A1
(de)
|
1993-12-17 |
1995-06-22 |
Hoechst Ag |
Heteroaromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
|
DE4409501A1
(de)
|
1994-03-19 |
1995-09-21 |
Didier Werke Ag |
Verschleißfutter eines Schachtofens und Stein hierfür
|
|
DE69526790T2
(de)
|
1994-06-24 |
2003-03-06 |
Euroceltique S.A., Luxemburg/Luxembourg |
Verbindungen zur hemmung von phosphodiesrerase iv
|
|
US5789434A
(en)
|
1994-11-15 |
1998-08-04 |
Bayer Corporation |
Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
|
|
TW424087B
(en)
|
1995-04-06 |
2001-03-01 |
Janssen Pharmaceutica Nv |
1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives
|
|
TW332201B
(en)
|
1995-04-06 |
1998-05-21 |
Janssen Pharmaceutica Nv |
1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
|
|
US6037370A
(en)
|
1995-06-08 |
2000-03-14 |
Vertex Pharmaceuticals Incorporated |
Methods and compositions for stimulating neurite growth
|
|
KR19990076788A
(ko)
|
1996-01-22 |
1999-10-15 |
후지야마 아키라 |
티아졸릴벤조푸란 유도체 및 그를 함유하는 약제학적 조성물
|
|
AU4015497A
(en)
|
1996-08-26 |
1998-03-19 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Thiazole derivatives useful as selective inhibitors of pde-iv
|
|
JPH1087543A
(ja)
|
1996-09-17 |
1998-04-07 |
Chisso Corp |
アルコキシベンゼン誘導体、液晶組成物および液晶表示素子
|
|
US6548490B1
(en)
|
1997-10-28 |
2003-04-15 |
Vivus, Inc. |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
WO1999045914A1
(en)
|
1998-03-13 |
1999-09-16 |
Maruho Kabushikikaisha |
Alkyl amine derivative and local anesthetic agent using the same
|
|
GB9807354D0
(en)
|
1998-04-07 |
1998-06-03 |
Glaxo Group Ltd |
Antiviral compound
|
|
SE9804212D0
(sv)
|
1998-12-04 |
1998-12-04 |
Astra Pharma Prod |
Compounds
|
|
PL350357A1
(en)
|
1999-03-12 |
2002-12-02 |
Boehringer Ingelheim Pharma |
Heterocyclic urea and related compounds useful as anti−inflammatory agents
|
|
US7141593B1
(en)
|
1999-06-04 |
2006-11-28 |
Abbott Laboratories |
Pharmaceutical formulations
|
|
GB9929552D0
(en)
|
1999-12-14 |
2000-02-09 |
Proteus Molecular Design |
Compounds
|
|
US7119098B2
(en)
|
2000-06-15 |
2006-10-10 |
Pharmacia Corporation |
Heteroarylakanoic acids as intergrin receptor antagonists
|
|
US20030032579A1
(en)
|
2001-04-20 |
2003-02-13 |
Pfizer Inc. |
Therapeutic use of selective PDE10 inhibitors
|
|
ES2310886T3
(es)
|
2001-05-22 |
2009-01-16 |
Pfizer Products Inc. |
Nueva forma cristalina de azitromicina.
|
|
EP1499662A1
(en)
*
|
2002-04-18 |
2005-01-26 |
Avecia Limited |
Prepation of a conjugated molecule and materials for use therein
|
|
US6821502B2
(en)
|
2002-06-12 |
2004-11-23 |
Chevron U.S.A. Inc. |
Method of making aluminum-containing zeolite with IFR structure
|
|
KR20050025189A
(ko)
|
2002-07-27 |
2005-03-11 |
아스트라제네카 아베 |
화학 화합물
|
|
ATE431342T1
(de)
|
2002-10-08 |
2009-05-15 |
Scripps Research Inst |
Inhibitoren von fettsäureamidhydrolase
|
|
US20060128695A1
(en)
|
2002-10-30 |
2006-06-15 |
Neuro3D |
Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
|
|
TW200410921A
(en)
|
2002-11-25 |
2004-07-01 |
Hoffmann La Roche |
Mandelic acid derivatives
|
|
JP4464280B2
(ja)
|
2002-12-06 |
2010-05-19 |
興和株式会社 |
エリスロポエチン産生促進剤
|
|
BR0317600A
(pt)
|
2002-12-20 |
2005-11-29 |
Pharmacia Corp |
ácidos heteroarilalcanóicos como derivados de antagonistas de receptor de integrina
|
|
WO2004071509A1
(ja)
|
2003-02-12 |
2004-08-26 |
Nippon Chemiphar Co., Ltd. |
オリゴデンドロサイト分化促進剤
|
|
BRPI0409888A
(pt)
|
2003-04-18 |
2006-05-23 |
Memory Pharm Corp |
derivados de pirazol como inibidores de fosfodiesterase 4, composto, composição farmacêutica, método para efetuar a inibição da enzima pde4, incrementar a cognição e/ou tratar a psicose em um paciente, método para o tratamento de um paciente que tem uma doença que envolve nìveis de camp diminuìdos, método para o tratamento de um paciente que sofre de uma doença alérgica ou inflamatória e método para o tratamento de um paciente que sofre de neurodegeneração resultante de uma doença ou de um ferimento
|
|
AR047541A1
(es)
|
2004-02-13 |
2006-01-25 |
Sandoz Ag |
Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
|
|
WO2005103022A1
(en)
|
2004-04-20 |
2005-11-03 |
Transtech Pharma, Inc. |
Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
|
|
WO2005110410A2
(en)
*
|
2004-05-14 |
2005-11-24 |
Abbott Laboratories |
Kinase inhibitors as therapeutic agents
|
|
US7351833B2
(en)
|
2004-07-23 |
2008-04-01 |
Abbott Laboratories |
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
|
|
US7449486B2
(en)
*
|
2004-10-19 |
2008-11-11 |
Array Biopharma Inc. |
Mitotic kinesin inhibitors and methods of use thereof
|
|
US8436176B2
(en)
|
2004-12-30 |
2013-05-07 |
Medicis Pharmaceutical Corporation |
Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
|
|
ATE472543T1
(de)
|
2005-01-07 |
2010-07-15 |
Pfizer Prod Inc |
Heteroaromatische chinolinverbindungen und deren verwendung als pde10-inhibitoren
|
|
KR101340859B1
(ko)
|
2005-02-04 |
2013-12-13 |
세노믹스, 인코포레이티드 |
연결형 헤테로 아릴 잔기를 포함한 화합물, 및 식용조성물을 위한 신규의 우마미 향미 개선제, 맛 촉진물질 및맛 향상제로서의 그의 용도
|
|
CA2605603A1
(en)
|
2005-04-22 |
2006-11-02 |
Kalypsys, Inc. |
Ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
MY152185A
(en)
|
2005-06-10 |
2014-08-29 |
Novartis Ag |
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
|
|
AU2006278592A1
(en)
|
2005-08-04 |
2007-02-15 |
Apogee Biotechnology Corporation |
Sphingosine kinase inhibitors and methods of their use
|
|
RS52318B
(sr)
|
2005-08-29 |
2012-12-31 |
Sanofi-Aventis U.S. Llc |
Novi kristalni oblik derivata piridazino [4,5-b] indola
|
|
EP2107066A3
(en)
|
2005-09-13 |
2009-10-21 |
Sicor, Inc. |
Processes for the synthesis of rocuronium bromide
|
|
US8637559B2
(en)
|
2005-11-15 |
2014-01-28 |
Otsuka Pharmaceutical Co., Ltd. |
Oxazole compound and pharmaceutical composition
|
|
EP1968946A4
(en)
|
2005-12-23 |
2010-05-05 |
Astrazeneca Ab |
IMIDAZOLE AS MODULATORS OF THE GABA B RECEPTOR
|
|
CA2650976A1
(en)
|
2006-05-02 |
2007-11-15 |
Pfizer Products Inc. |
Bicyclic heteroaryl compounds as pde10 inhibitors
|
|
US20080090834A1
(en)
|
2006-07-06 |
2008-04-17 |
Pfizer Inc |
Selective azole pde10a inhibitor compounds
|
|
WO2008031014A1
(en)
|
2006-09-08 |
2008-03-13 |
Ore Pharmaceuticals Inc. |
Method for reducing or alleviating inflammation in the digestive tract
|
|
CL2007002743A1
(es)
|
2006-09-25 |
2008-07-11 |
Pct Therapeutics Inc Soc Organ |
Forma cristalina del acido 3-[5-(2-fluorofenil)-[1,2,4]oxadiazol-3-il]-benzoico; composicion farmaceutica que comprende a dicha forma cristalina; y su uso para modular la terminacion prematura de traslado o decaimiento de marn, tales como carcicoma.
|
|
EP2079462A4
(en)
|
2006-09-28 |
2009-12-02 |
Merck & Co Inc |
PHARMACEUTICAL COMPOSITIONS OF HDAC INHIBITORS AND CHELABLE METAL COMPOUNDS AND METALO HDAC HEMMER CHELATE COMPLEXES
|
|
WO2008040669A2
(en)
|
2006-10-02 |
2008-04-10 |
Janssen Pharmaceutica N.V. |
Novel intermediates for the preparation of a glyt1 inhibitor
|
|
US7837978B2
(en)
|
2006-10-13 |
2010-11-23 |
Chevron U.S.A. Inc. |
Process for preparing aluminum-containing molecular sieve SSZ-26
|
|
US7786139B2
(en)
|
2006-11-21 |
2010-08-31 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
EP2083819B1
(en)
*
|
2006-11-21 |
2017-02-22 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
PE20081506A1
(es)
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
|
WO2009008906A2
(en)
|
2007-02-06 |
2009-01-15 |
The Trustees Of The University Of Pennsylvania |
Therapeutic compounds for blocking dna synthesis of pox viruses
|
|
AU2008253803A1
(en)
|
2007-05-22 |
2008-11-27 |
Ultimorphix Technolgies B.V. |
Tenofovir disoproxil hemi-fumaric acid Co-crystal
|
|
EP2017264A1
(de)
|
2007-07-16 |
2009-01-21 |
Bayer Cropscience Ag |
Substituierte Phenylpropargylverbindungen, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
US20090186014A1
(en)
|
2007-10-10 |
2009-07-23 |
Ore Pharmaceuticals Inc. |
Method for treatment of pancreatitis
|
|
TW200944520A
(en)
|
2008-01-29 |
2009-11-01 |
Glaxo Group Ltd |
Spiro compounds as NPY Y5 receptor antagonists
|
|
WO2009143178A2
(en)
|
2008-05-20 |
2009-11-26 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
TWI501965B
(zh)
|
2008-06-20 |
2015-10-01 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
|
|
CN102143752B
(zh)
*
|
2008-08-05 |
2014-12-10 |
奥默罗斯公司 |
Pde10抑制剂以及相关组合物和方法
|
|
AU2011224287B2
(en)
*
|
2010-03-12 |
2015-03-26 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
NZ630803A
(en)
*
|
2014-04-28 |
2016-03-31 |
Omeros Corp |
Optically active pde10 inhibitor
|